Lakeview Capital Partners »

BioCryst Pharmaceuticals shares owned by Lakeview Capital Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Lakeview Capital Partners from 13F filings

Historical chart of Lakeview Capital Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Lakeview Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Lakeview Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $911k 152k 5.99
2023-09-30 $1.1M 151k 7.08
2023-06-30 $1.1M 151k 7.04

More positions owned by Lakeview Capital Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Biohaven (BHVN)
Amazon (AMZN)
Listed Fd Tr Shares Lag Cap (OVL)
Ishares Tr Short Treas Bd (SHV)
JPMorgan Chase & Co. (JPM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
Alphabet Cap Stk Cl C (GOOG)
Home Depot (HD)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)

View all positions for Lakeview Capital Partners

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Braidwell
Kynam Capital Management
Deerfield Management Company
Fisher Investments
Two Sigma Investments
Jennifer Ranahan
Two Sigma Advisers
Millennium Management
Norges Bank Investment Management
Rice Hall James & Associates
Balyasny Asset Management
Stifel Financial

View all funds holding BioCryst Pharmaceuticals